Not applicableNot Yet RecruitingNCT07305363
What this trial is testing
A Prospective, Open-label, Single-arm, Investigator-initiated Study (SELIC) to Evaluate the Efficacy and Safety of Seladelpar in Adult Liver Transplant Recipients With Ischemic Cholangiopathy (IC).
Who this might be right for
Liver Transplant; ComplicationsIschemic Cholangiopathy
University of California, San Diego 10